Similar Papers

Paper Title
Journal
Date
Author
Preventing the Progression of Osteoarthritis by Inhibiting the NF-κB/p65 Pathway
Meng Lv ... Tianjian Zhou
Nanoscience and Nanotechnology Letters | VOL. 9
Meng Lv, et. al.Meng Lv ... Tianjian Zhou
01 Dec 2017
A1.19 Zinc and cadmium homeostasis is altered in rheumatoid arthritis synoviocytes
Paola Bonaventura ... Aline Lambroux
Annals of the Rheumatic Diseases | VOL. 73
Paola Bonaventura, et. al.Paola Bonaventura ... Aline Lambroux
31 Jan 2014
In vitro effects of erythromycin on RANKL and nuclear factor-kappa B by human TNF-α stimulated Jurkat cells
Lan Wu ... Wei-Ge Zhang
International Immunopharmacology | VOL. 9
Lan Wu, et. al.Lan Wu ... Wei-Ge Zhang
02 Jun 2009
GACAT3 promoted proliferation of osteoarthritis synoviocytes by IL-6/STAT3 signaling pathway.
...
European Review for Medical and Pharmacological Sciences | VOL. 22
, et. al. ...
01 Aug 2018
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
Greetings from the Editor - 2025.
Josef Smolen
Annals of the rheumatic diseases | VOL. 84
Josef SmolenJosef Smolen
01 Jan 2025
Bridging the gap: tackling the challenge of limited progressors in clinical trials aimed at slowing the transition from early preradiographic to established osteoarthritis.
Francis Berenbaum ... Marc Buyse
Annals of the rheumatic diseases | VOL. 84
Francis Berenbaum, et. al.Francis Berenbaum ... Marc Buyse
01 Jan 2025
Systematic literature review and meta-analysis informing the EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer.
Eden Sebbag ... Jacques-Eric Gottenberg
Annals of the rheumatic diseases | VOL. -
Eden Sebbag, et. al.Eden Sebbag ... Jacques-Eric Gottenberg
20 Dec 2024
2024 EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer
Eden Sebbag ... Jacques-Eric Gottenberg
Annals of the Rheumatic Diseases | VOL. -
Eden Sebbag, et. al.Eden Sebbag ... Jacques-Eric Gottenberg
19 Dec 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.